Outbound Lead Generation for Biotech & Pharmaceutical
Most biotech and pharma companies rely on conferences, referrals, and inbound -- channels that move too slowly when you need to book meetings with hospital systems, research institutions, or pharma partners. Your sales cycle is already 9-18 months. Waiting another 6 months to build a predictable pipeline isn't an option. Chiefscale runs your entire outbound system: personalized email, LinkedIn outreach, and speed-to-lead calling. Every warm reply gets a call within 60 minutes from your dedicated operator.
The problem you already know
- You're stuck in a referral-dependent sales model where growth is unpredictable and pipeline visibility is nonexistent. Conference season brings a burst of leads, then nothing for months. You need consistent deal flow to hit revenue targets and support R&D investment, but you don't have the bandwidth to build an outbound function from scratch.
- Your ICP includes clinical directors, procurement heads, research coordinators, and medical affairs teams -- personas that don't respond to generic outreach. Every message needs to reference therapeutic areas, regulatory pathways, or clinical outcomes. Your internal team doesn't have time to write 100+ personalized emails per week while managing ongoing trials and partnerships.
- Long sales cycles mean you need 30-50 active conversations in pipeline at all times just to close 3-5 deals per quarter. But your team is underwater with product development, regulatory submissions, and existing client management. Outbound gets deprioritized, and pipeline dries up six months later when you need it most.
- You've tried hiring SDRs or using software like Apollo, but they don't understand the nuances of biotech sales. Cookie-cutter templates get ignored. Data providers give you outdated contacts. You need a system that understands compliance, therapeutic areas, and how to speak to clinicians and researchers without sounding like a vendor.
How Chiefscale handles this
We build your outbound system around the clinical and procurement personas that actually buy biotech and pharma products. Our operators research therapeutic areas, institutional priorities, and regulatory timelines before writing a single message. We use personalized email sequences that reference specific challenges -- formulary adoption, patient outcomes, supply chain reliability, or clinical evidence requirements. LinkedIn outreach targets decision-makers at hospital systems, research institutions, health plans, and pharma partners. Every warm reply gets a call within 60 minutes from your dedicated operator who understands your science and value proposition. We integrate with your CRM, manage dedicated sending domains to protect your reputation, and deliver bi-weekly pipeline reports. You get 8-15 qualified conversations per month without hiring, training, or managing an SDR team.
Who we target for you
A biologics manufacturer targeting clinical directors and pharmacy buyers at 200+ bed hospital systems in the Northeast. A diagnostics company reaching lab directors and pathology department heads at academic medical centers. A contract research organization prospecting clinical operations managers at mid-size pharma companies running Phase II and III trials. A medical device startup connecting with surgical directors and value analysis committees at integrated delivery networks.
The system, applied to your market
Week 1: ICP definition, list building, and persona research. We identify hospital systems, research institutions, pharma partners, or health plans that match your criteria. Week 2: Message development and operator onboarding. We write sequences that reference therapeutic areas, clinical outcomes, and institutional priorities. Week 3: Campaign launch across email and LinkedIn. Your dedicated operator begins speed-to-lead calling on every warm reply. Week 4+: Ongoing outreach, response handling, and bi-weekly reporting. We refine messaging based on reply data and book 8-15 qualified conversations per month directly into your calendar.
What to expect
Expect 5-12% reply rates from clinical directors, procurement teams, and research coordinators. 8-15 qualified conversations per month with decision-makers who control budgets for therapeutics, diagnostics, or services. Average time-to-first-meeting: 12-18 days from campaign launch. Most biotech and pharma clients see positive ROI within 90 days as the pipeline builds and early-stage deals progress through clinical evaluation and procurement review.
Frequently asked questions
Do you understand regulatory and clinical terminology?
Yes. Our operators research therapeutic areas, regulatory pathways, and clinical evidence requirements before writing outreach. We reference FDA approvals, formulary dynamics, patient outcomes, and institutional priorities. We don't send generic software pitches.
Can you target hospital systems and academic medical centers?
Yes. We build lists of clinical directors, pharmacy buyers, lab directors, research coordinators, and value analysis committee members at institutions that match your ICP. We filter by bed count, health system affiliation, therapeutic focus, and geography.
Will this work if we have a 12-18 month sales cycle?
Yes. Long sales cycles require consistent top-of-funnel activity. We generate 8-15 qualified conversations per month so you always have 30-50 active opportunities in pipeline. Early-stage deals take time, but the system pays for itself when those deals close.
Do you call warm replies within 60 minutes?
Yes. Every positive response -- whether email or LinkedIn -- gets a call from your dedicated operator within 60 minutes during business hours. Speed-to-lead calling dramatically increases conversion from reply to booked meeting, especially with busy clinical and procurement personas.
What if we sell to pharma partners, not hospitals?
We adjust targeting accordingly. For pharma BD outreach, we target heads of business development, clinical operations managers, and therapeutic area leads at companies running trials or seeking partnerships. Same system, different ICP.